This is especially important because secreted FABP4 was correlated with obesity-related breast cancer [39] and its secretion from adipocytes in individuals with obesity is correlated with adipocyte hypertrophy, harmful effects on other tissues, and insulin resistance [40]. Here, FABP4 is linked to breast carcinoma.